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Abstract: 
Background and aim. Artificial nutrition by intravenous feeding has for decades indicated less than 
optimal support of whole-body protein metabolism and balance during some treatment conditions. 
Therefore, the present project was aimed to evaluate the role and effects by amino acid provision to 
skeletal muscle cells in the light of other known important factors as amino acid infusion kinetics, 
IGF-I and insulin in support of myofibrillar protein synthesis. 
Methods. Murine L6 and human rhabdomyosarcoma cells were cultured at standardized conditions in 
the presence of various amino acid concentrations. Commercially available amino acid formulations 
were infused by constant rates to patients scheduled for elective surgery and to ICU patients. 
Transgenic female mice with selective knockout of the IGF-I gene in hepatocytes were used in 
refeeding experiments to evaluate the role of circulating IGF-I for muscle protein synthesis, which was 
estimated by the flooding dose technique ([14C]-phenylalanine). Protein factors for translational 
control of protein synthesis and cell signaling (4E-BPI, eIF4E, p70s6k, mTOR) were estimated in 
Western blots. Transcripts of muscle IGF-I, IGF-IR, PI3-kinase, AKT, mTOR, acta 1 (α-actin), 
mhc2A (myosin) and slc38a2/Snat 2 (amino acid transporter) were quantified by qPCR. Plasma amino 
acids were measured by HPLC. 
Results. Incorporation rate of amino acids into muscle proteins gave incorrect results in a variety of 
experimental conditions. Methods independent of labeled amino acids (ribosome profiles, initiation 
factor analyses) indicated that essential amino acids activate initiation of protein translation, while 
non-essential amino acids had no such effects. Insulin at physiologic concentration (100 μM/ml) did 
not stimulate global muscle protein synthesis, but did so at supraphysiologic concentrations (3mU/ml). 
Circulating IGF-I was not critical for activation of muscle protein translation, while tissue produced 
IGF-I and IGF-IR controlled feeding induced protein synthesis, which involved mTOR signaling in 
skeletal muscles. In general, provision of exogenous amino acids was related to plasma concentrations 
and probably to steady state levels of amino acids in peripheral tissues of patients. Amino acids caused 
activation of translation initiation of muscle proteins as demonstrated for myosin heavy chain and α-
actin. These effects by amino acids were in part supported by increased transcription and utilization of 
amino acid transporters as Snat 2 mRNA in muscles. Microarray analysis indicated up-regulation of 
genes in the mevalonate-pathway following amino acid exposure, important for steroidogenesis and 
lipid metabolism, which may imply new and additional mechanisms behind anabolic reactions in 
muscle cells related to nutrition. 
Conclusion. Our results re-emphasize that labeled amino acids should be used with great caution for 
quantification of muscle protein synthesis. Measurements of regulating factors in the control of 
initiation of muscle protein synthesis represent alternative and convenient applications in estimation of 
directional changes in protein synthesis during non steady state conditions as demonstrated by 
overnight preoperative provision of standard TPN to patients. Our results confirm that muscle cells are 
sensitive to alterations in extracellular concentrations of amino acids, which signal to activate 
translation of transcripts for myofibrillar proteins. Such dynamics are highly dependent on the 
presence of membrane transporters of amino acids.  
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INTRODUCTION 
 
Complications are significantly increased postoperatively in hospitalized and malnourished 
patients (1). It is therefore obvious and confirmed that systematic nutritional support reduces 
morbidity and mortality during treatment of cancer disease (2). However, years of clinical 
experience underlines difficulties to improve protein status in catabolic patients on artificial 
nutrition (3). For years, this fact made our research group to focus on mechanisms behind 
induction of protein anabolism in peripheral tissues both in healthy volunteers and in weight 
losing patients subsequent to various disease conditions (4). The earlier results demonstrate 
that conventional artificial nutrition attenuates further weight loss and protects body 
composition to some extent, but it remains difficult to support a clear-cut re-synthesis of body 
proteins, particularly in skeletal muscles (5). Thus, it remains a challenge to understand 
important factors behind stimulation of protein synthesis during normal and artificial feeding 
in patients.  
 
Chronically malnourished patients have been evaluated in previous investigations during both 
enteral and parenteral nutrition. The results demonstrated that fat and carbohydrate 
metabolism were reasonably adequate (4), while insufficient induction of protein synthesis 
seemed to be related to the kinetics of infused amino acids (6). We therefore evaluated 
potential effects by insulin, recombinant IGF-I and ghrelin for anabolism in provision to 
malnourished patients. These studies demonstrated that effects by insulin were not significant 
in contrast to traditional opinions regarding muscle protein synthesis (7), while IGF-I was 
more potent although it did not improve nitrogen balance in postoperative surgical patients 
(8). However, ghrelin had clear cut effects to improve fat synthesis, and also implied a trend 
in effects to improve muscle anabolism (9). Therefore, continuing research is now focused on 
factors that may stimulate protein synthesis in skeletal muscles during both normal feeding 
and artificial nutrition. Such a stimulation appears not to be a matter of neural innervation, 
since denervated skeletal muscles showed normal activation of protein synthesis during re-
feeding (10) , which was also observed in mice with type I and type II diabetes (11).  
 
Our investigations in man have preferentially been conducted by measurements of amino acid 
balances across resting and exercising arms and legs (6, 12). Methods for measurement of 
protein synthesis also included applications of stable isotopes (12, 13). In addition, methods to 
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measure the release of 3-methylhistidine (3MH) from skeletal muscles were developed (14). 
The combination of stable isotopes and release of 3MH allowed determination of protein 
breakdown of sarcoplasmic and myofibrillar proteins in muscle tissue (15). Usually, these 
techniques do however not give complete and detailed information about the control of 
protein synthesis in vivo, which is usually used as a unanimous concept in the scientific 
literature, although there are a large number of proteins with specific regulation, functions and 
different turnover. Therefore, techniques that made it possible to distinguish alterations 
among different proteins were applied. This approach demonstrated that proteins with basic 
isoelectric points showed decreased synthesis in conditions of partial starvation, while 
“neutral proteins” appeared moderately decreased and “acid proteins” were surprisingly 
unaffected (10, 16). Thus, a traditional conceptual view with an overall decreased protein 
synthesis in skeletal muscles during partial starvation represents a too simplistic conclusion. 
We have therefore tried to combine methods to evaluate transcription and measurements of 
phosphorylation/de-phosphorylation and subsequent association of initiating protein 
complexes for the translational process (17). Experiments in animals as well as in cultured 
murine L6- and human rhabdomyosarcoma cells were evaluated for expression of mRNA for 
IGF-I, IGF-IR and GH-R at starvation-refeeding and following stimulation by hormones 
(insulin, IGF-I, GH) and growth factors. These studies confirmed that our methods are 
sensitive enough to measure physiological alterations related to preoperative intravenous 
feeding in humans (18).  
 
In the present studies we have focused on physiological experiments to evaluate the role of 
locally produced IGF-I and IGF-IR in muscle cells to promote effects by amino acids to 
induce initiation of protein translation in muscle. These experiments involved measurements 
of rate controlling steps for initiation of translation as binding eIF4E to m7GTP at the 5′ part 
of mRNA and subsequent binding of eIF4E mRNA complex to eIF4G and eIF4G binding to 
eIF4A and eIF3. The phosphorylation state of these proteins was altered by refeeding in 
normal mice, cultured cells and muscle tissue biopsies from patients (17, 18). Transduction 
signals behind the stimulatory networks have not yet been entirely clarified, but may be 
related to the transport carrier of amino acids across the cell membrane, which is now a focus 
of our ongoing research program, since tissue and cell expression of amino acid transporters 
are reported to be altered by provision of amino acids in various applications as presented in 
my thesis. Future research will be focused on the signal pathway(s) behind amino acid 
stimulation of myofibrillar proteins synthesis (myosin, actin) in skeletal muscles. An ultimate 
 11 
goal of the present thesis was therefore to create a methodological basis for future 
translational and clinical studies that may facilitate and optimize nutritional treatment and 
supportive care to hospitalized and malnourished patients in combination with additional 
medical treatments.  
 
 
 
AIMS OF THE PRESENT STUDY 
 
It is likely that nutritional treatment is still less than optimal in several clinical conditions 
connected with severe disease, particularly concerning re-synthesis of skeletal muscle 
proteins. This phenomenon is in part associated with insufficient ability of artificial nutrition 
to stimulate protein synthesis to the extent as observed after oral refeeding, Therefore, an 
increased knowledge is required to understand how amino acids and hormones interact to 
control initiation of protein synthesis in cells.  
 
Specific aims were: 
 
to re-evaluate effects of amino acids for activation of protein synthesis in muscle cells by 
comparing results from different applications and methods (I and V). 
 
to apply both new and well-recognized scientific methods for monitoring translation 
initiation of protein synthesis in human skeletal muscle tissue in order to optimize 
intravenous feeding in conjunction with surgical treatments (II and III). 
 
to investigate the role liver derived IGF-I may have to stimulate feeding induced protein 
synthesis in skeletal muscle tissue in vivo (IV). 
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METHODOLOGICAL CONSIDERATIONS 
 
A combination of methods and study models were used to investigate different aspects related 
to activation of protein synthesis after different kinds of feeding in our present studies. 
Animal models and cell culture experiments were mainly used with subsequent evaluations in 
clinical applications on patients. Applied methodology is described in brief and discussed 
from a general perspective, since all methods are described in detail in paper I-V.  
 
 
Experimental and clinical models 
Animal models 
A starvation-refeeding model of mice was used to evaluate the effect of feeding on activation 
of protein synthesis and intracellular signaling in skeletal muscles. Adult, female C57Bl/6 
mice of 20-22 g body weight were used (Paper I and V). All animals were housed in ordinary 
plastic cages with bedding and had free access to water at all conditions. Mice were 
transferred to new cages upon removal of food at 8 pm. They were either starved overnight 
for 12 hours before killing; starved overnight and thereafter refed for 3 hours with standard 
rodent chow before killing; or were freely fed with access to food continuously. A 3 hour 
refeeding period was used as we have previously demonstrated that fractional protein 
synthesis rate in skeletal muscles was close to maximum at this time post-feeding. Mice were 
preferred over rats as experimental animals, since mice are weight stable, non-growing 
animals as adults. 
 
Transgenic mice with selective and inducible knockout of the IGF-I gene in liver cells were 
used to evaluate the role of liver-derived IGF-I for activation of protein synthesis after feeding 
and these mice were starved and refed as described above (Paper IV). Knockout mice were 
created by others using the Cre/LoxP conditional knockout system (19). Injections with 
polyinosinic-polycytidylic acid (PIPC) results in a specific and complete inactivation of the 
IGF-I gene in hepatocytes, which will cause IGF-I in the circulation to decrease by 70-80%. 
The mRNA expression of IGF-I in skeletal muscle tissue is however unaffected in this model 
upon silencing of liver IGF-I expression, which makes it possible to separate effects of local 
IGF-I produced in the muscle cells from liver-derived IGF-I appearing in the blood 
circulation. PIPC treated littermates, homozygos for lox P but lacking Mx-Cre, served as 
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controls. Plasma IGF-I concentrations were measured in all mice groups 1 week after PIPC 
treatment to confirm decreased plasma IGF-I levels in knock out animals before animals were 
used in refeeding experiments. 
 
Cell culture experiments 
Standard cell culture media as used for growth and maintenance of cells contain high 
concentrations of amino acids. Therefore, a model with initial amino acid starvation of cells 
was developed in order to create conditions for studies of activation of cellular protein 
synthesis by amino acid exposure. Cells were always cultured to confluence before a period 
of amino acid starvation started, in order to create conditions to measure protein synthesis 
related to “feeding effects” of amino acids. This approach may minimize the influence of 
increased protein synthesis related to stimulation of cell proliferation upon such triggers. 
Then, when cells became confluent they were first exposed to a medium with reduced amino 
acid concentrations for 24 hours, and thereafter amino acids were provided in either low 
(starved cells) or normal (refed cells) concentrations for 18 hours of further culture. Rat L6 
myoblasts originating from rat thigh skeletal muscle and a human rhabdomyosarcoma cell 
line (RD) were used. L6 cells were used in the majority of our experiments. These cells fuse 
in culture to form multinucleated myotubes and exhibit many properties of mature muscle 
cells recognized in skeletal muscle tissue (20). RD cells were essentially used to confirm 
results from L6 cells in a human cell line (Paper I).  
 
Cell culture experiments were used as a complement to in vivo studies as it makes it possible 
to study cellular events under relatively stable and standardized conditions and makes it 
possible to study effects by amino acids separated from other stimuli such as hormones. 
Foetal calf serum (FCS) was therefore removed from the culture medium at the beginning of a 
starvation period. This was well tolerated by both cell lines and did not affect cell viability 
according to visual inspection. It must however be emphasized that cells in culture are not 
equivalent to muscle tissue in vivo with respect to cell differentiation or cell content of 
contractile myofibrillar proteins (21). Contents of cell surface receptors and intracellular 
signaling pathways may also differ between cultured cells and muscle cells in vivo (22).  
 
Clinical studies 
Two kinds of patient groups were recruited in studies on patients who would benefit from 
nutritional support. One investigation was aimed to evaluate to what extent different amino 
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acid compositions of amino acids solutions for clinical nutrition may affect the appearance of 
steady state concentrations of arterial amino acids in plasma (Paper II). These patients were 
treated at the ICU department at Sahlgrenska University hospital due to various severe 
conditions. They were included for investigations when deemed to need parenteral nutrition 
for clinical reasons for at least 1 week. If so, they received three different, commercially 
available amino acid solutions with different amino acid compositions (Vamin 18, Vamin-
Glucos, Glavamin). All patients received subsequently all three solutions and each solution 
was infused during 24 hours in random order to minimize carry-over effects. Arterial blood 
samples for analyses of plasma amino acids and substrates were drawn at the end of each 
infusion period. Amino acids were infused together with fat and carbohydrates. Amino 
nitrogen corresponded to 0.2gN/Kg body weight·day-1 and the energy intake of glucose and 
lipids was 20 kcal/kg/day with a caloric glucose to lipid ratio of 60:40 (23). The applied 
infusion rate was based on our earlier demonstration that amino acid flux switched from net 
outflow to net inflow across peripheral tissues in healthy individuals as well as in patients 
(12). Amino acid concentrations from a group of male healthy volunteers eating a 
standardized meal served as a reference group in comparison to amino acid profiles in 
peripheral blood of our patients. 
 
Twelve patients who underwent surgery in the upper gastrointestinal tract were included in 
another study (Paper III), where the purpose was to evaluate if a standard TPN regimen could 
activate translation initiation factors in skeletal muscles. These patients were randomized to 
receive overnight infusions of either saline or total parenteral nutrition, which was supplied as 
all in one bag (Kabiven Perifer). Amino nitrogen corresponded to 0.16 gN/Kg body 
weight·day-1 and energy intake was glucose and lipids at 30 kcal/Kg·day-1 with a glucose ratio 
of about 45 %. The infusion rate was chosen to represent a standard TPN regimen used in 
most clinical settings. Infusions lasted for at least 12 hours before operation and continued 
until biopsies for measurements of translation initiation factors were taken from the rectus 
abdominal muscle directly after anesthesia induction. Muscle biopsies were immediately 
placed in RNA later solution and stored at + 4 °C for 24 hours before storage at -20 °C. This 
handling preserved initiation factor complexes better than immediate snap freezing in liquid 
N2 and storage at -70°C, and made it possible to collect samples from patients appearing over 
a period of time which would have been a major problem otherwise because of the labile 
nature of such protein complexes. 
 
 15 
Measurements of protein synthesis 
Isotope based methods 
The flooding dose technique was used to measure protein synthesis rate in vivo in animal 
experiments (24, 25). This method is based on administration of radioactive amino acid 
(tracer) together with a large amount of the same unlabelled amino acid (tracee). A flooding 
dose of phenylalanine leads to a plasma concentration of phenylalanine 5-10 times higher 
than normal, when provided at 150 µmol phe/100g and 0.4 µCi L-[U- 14C]-phenylalanine. In 
this way it is assumed that the large amount of the tracee amino acid rapidly equilibrates to 
extinguish differences in the specific radioactivity of phenylalanine between extra- and intra- 
cellular pools of phenylalanine. This would also minimize effects of different tracer/tracee 
ratios among different groups of animals in experiments. Variations that might exist due to 
differences in nutritional status or stress factors among animals. The flooding dose approach 
for measurement of protein synthesis in vivo is not suitable for any choice of amino acid. 
Theoretically, it should thus be an amino acid with comparatively low physiologic 
concentration difference between plasma to extracellular to intracellular concentrations. 
Besides, the amino acid should be comparatively slowly metabolized in any organ tissue and 
it should be easily dissolved in water. Thus, phenylalanine is one of the most appropriate 
amino acids based on such circumstances.  
 
In cell culture experiments, pulse labeling was used where the tracer (35-S-methonine) was 
diluted in the cell culture medium at the beginning of a refeeding period. In a monolayer cell 
culture it is assumed that steady state equilibrium of amino acids occur, which creates an even 
distribution of the tracer between extra- and intra-cellular pools for incorporation of the 
labeled amino acid into proteins. The protein synthesis rate can then be calculated according 
to the formula: R= [dpm/μg protein (cells)]/[dpm/nmol]; 
where dpm/μg is the specific radioactivity of the labeled amino acid in proteins at the end of 
incorporation and dpm/nmol is the constant specific radioactivity of the labeled amino acid in 
the immediate precursor pool (incubation medium) throughout the incubation period. 
 
Immuno precipitation and Western Blotting 
Measurements of changes in translation initiation factor complexes may be one possibility to 
evaluate protein synthesis activation with a tracer independent method without pool 
assumptions. A rate limiting step in the initiation phase of protein synthesis is binding of 
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mRNA to the cap binding protein eIF4E and assembly of the eIF4F complex (eIF4E, eIF4G, 
eIF4A). Complex formation is inhibited when the eIF4E protein is blocked by 4E-binding 
protein 1 (4E-BP1) (26). Total cell proteins are first immunoprecipitated, in isolation of 
initiation complex formations, with an anti eIF4E antibody to collect the mRNA cap binding 
protein eIF4E together with attached proteins followed by electrophoretic separation and 
transfer of the proteins to a binding surface membrane. Such membranes are thereafter treated 
with antibodies against eIF4G or 4E-BP1. Estimations of protein synthesis activation are 
made by comparing semi-quantitative increases or decreases of inhibitory (eIF4E·4E-BP1) or 
activating (eIF4E·eIF4G) complexes. Attachment of 4E-BP1 to eIF4E is regulated by 
phosphorylation. Unphosphorylated protein forms are bound to eIF4E, while phosphorylated 
4E-BP1 is unbound (27). Phoshorylation status of 4E-BP1 is then determined by 
electrophoretic separation of all phoshorylated forms. By these applications, activation of 
protein synthesis can be indicative. However, it may be uncertain to what extent initiated 
proteins are completely terminated during translation, even though small changes in 
phoshorylation status and complex formation between samples can be detected.  
 
Ribosome profiles 
Activation of protein synthesis was also evaluated by an additional tracer independent method 
in some of our experiments. Ribosomes in cells were separated by density centrifugation in a 
non-linear sucrose gradient (28, 29). In this way ribosomes can be separated according to size. 
After centrifugation, the sucrose gradients were pumped through an UV-detector, the 
absorbance at λ260 nm was measured and the area under the curve was registered. Multiple 
ribosomes in the process of translating mRNAs into proteins can then be separated from 
single ribosomes that are not involved in the translation process at the time of measurement. 
This method, which indicates the proportion of ribosomes in polysomes versus free- and 
subunits of ribosomes, gives a good estimate of increased translation but is not sensitive 
enough to reflect small changes in translational activity. 
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RNA metabolism 
RNA extraction 
An important factor in studies of mRNA expression is the quality of extracted tissue RNA. 
The RNA should be free from DNA and protein contamination and should not be degraded. 
All RNA preparations in our studies were isolated with RNeasy mini kit or RNeasy fibrous 
tissue mini kit (Qiagen) with a DNAse step included to remove contaminating DNA. RNeasy 
Kits are simple to use and produces RNA of high purity. RNA quality and concentration were 
always confirmed using a bioanalyzer (Agilent 2100, Agilent technologies) and nanodrop 
respectively (Nanodrop, Saveen &Werner).  
  
Real time PCR 
Transcripts of intracellular signaling pathways were measured by quantification of mRNA 
levels by real time PCR, which is a sensitive method for quantification of specific mRNAs 
(30-32). RNA is reverse transcribed into cDNA before PCR reactions. A primer pair is 
designed for the gene of interest preferably spanning an exon-exon boundary to allow 
amplification of cDNA but not of genomic DNA. The target sequence is then amplified in a 
PCR reaction. In the first step, the double-stranded DNA is heat denatured (95°C) into two 
single strands to allow binding of the primers, which are short, synthetic sequences of single 
stranded DNA. After annealing of the primers (usually at a temperature around 55-65°C) the 
temperature is raised to 72°C and a Taq DNA polymerase begins to synthesize new double 
stranded DNA at the 3’ end of the primer. There are two new DNA strands identical to the 
original target at the end of each cycle. The amount of synthesized DNA can be quantified by 
measurement of the fluorescence emission of SybrGreen I dye after each cycle. The dye has 
barely no fluorescence when it is free in solution, but the emission of fluorescence is greatly 
enhanced when it binds to double stranded DNA. Thus, the SybrGreen I signal correlates with 
the amount of product amplified during PCR. One problem of using SybrGreen I dye for 
detection is that the dye can bind to any double-stranded DNA and thus detect contaminating 
DNA in reverse transcribed RNA samples.  One way to overcome this problem is to use RNA 
specific primers spanning over an exon-exon, which does not allow amplification of genomic 
DNA. All our samples were also DNAse treated.  Another problem is that the dye may bind 
unspecifically at inappropriate annealing temperature. A melting curve analysis was therefore 
performed for all analyses to check that only one transcript was present. It was also verified 
that all PCR products had the expected base pair size. Quantitative results were produced with 
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the relative standard curve method (33). GAPDH were used as housekeeping gene in human 
and animal analyses with 18S rRNA in cell culture analyses, since GAPDH were not 
expressed at constant levels in our cultured cells.  
 
Expression (DNA) microarrays 
Microarray technology is a powerful tool to analyze expression levels (transcripts) of 
thousands of genes at the same time (34). Therefore, this technique was used to search for 
changes in transcript levels after amino acid refeeding in L6 cells (Paper V). Microarrays are 
produced by several manufacturers and the technology differs slightly between producers, but 
the core principle behind microarrays is hybridization between two DNA strands. Agilent 
Whole Rat Genome 4 x 44K expression arrays in combination with a 2 colour detection 
system was used in our present studies. In the Agilent arrays used, 60-mer oligonucleotide 
sequences (probes) are in situ synthesized on a glass slide. The 60-mer long probes are more 
specific to the target than shorter probes used in other systems like the 25-mer probes used by 
Affymetrix.  
 
RNA must first be transcribed into complimentary DNA (cDNA) by reverse transcription in 
order to detect RNA expression. In the Agilent system, samples are labeled with the 
fluorescent dyes in the cDNA synthesis step and RNA from starved and refed cells was 
labelled with either Cy3-dCTP or Cy5-dCTP respectively. These samples were then 
hybridized in competition on Whole Rat Genome 4 x 44K expression arrays, which generates 
a ratio of the difference between the two samples for each probe. A critical step in microarray 
studies is the data processing. After the fluorescence intensities were quantified in the Agilent 
G 2565 AA scanner, data were extracted and preprocessed with Feature Extraction software 
according to the manufacturer’s recommendations to obtain dye normalized, outlier- and 
background subtracted values to be used for further analysis. RNA from 4+4 independent 
samples were analyzed. The preprocessed values were imported into Genespring GX 10 
software (Agilent technologies) where probes with low signal to background ratio were 
excluded before further analysis. 
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Comments on protein synthesis methodology 
An ideal method for estimating the true rate of protein synthesis should minimally rely on 
assumptions, but such a method may not exist and will probably not be available because of 
the complexity involved in the building of cellular proteins. Methods based on incorporation 
of stable or radioactive isotopes are always based on assumptions on the incorporations from 
the tRNA pool, which theoretically should represent the immediate precursor pool for protein 
synthesis (35-45). Using estimations of protein synthesis from non-tracer based methods 
always leaves you with the question; is a new and complete protein finally created; and if so, 
to what extent? Tracer methods are good in the sense they provide a quantitative measure of 
protein synthesis, which is not obtained by other methods. Evaluations of activation of protein 
synthesis from phosphorylation changes in translation initiation factors provide information 
that the process has started but not that it was finally and correctly completed. It may have 
been interrupted during elongation or termination phases before completion. Ribosome 
profiles, on the other hand, provide you insights into the translation process and ribosome 
distribution. It probably gives a rather reliable indication of increased protein synthesis in one 
condition compared to another. It is however a tedious and time consuming method to 
perform, demanding comparatively large amount of tissue and cell material, and it can never 
provide information on small changes of protein synthesis activity. So, what is the method of 
choice? This is a question without a final answer. One must also keep in mind that cells 
contain thousands of proteins to add one more layer of complexity to this issue; and protein 
synthesis is usually referred to and conceptually regarded as an over-all protein synthesis 
phenomenon in cells. However, the most important proteins to synthesize in skeletal muscles 
may be myofibrillar proteins of the contractile muscle unit in weight-losing patients who 
would benefit from nutritional treatment. It is the protein composition and the presence of 
these proteins that determine the power and force generation in muscles (46). With loss of 
contractile proteins the muscle will be weak and its performance deteriorated. Studies also 
indicate that cytoplasmic and myofibrillar proteins are synthesized at different rates (10, 47). 
Therefore, analyses of mRNA transcrips of myofibrillar proteins as actin and myosin heavy 
chains may be used to reflect eventual changes of myofibrillar transcription and subsequent 
protein synthesis. Cellular concentrations of mRNA transcripts are however only a static 
measure of the amount of mRNA at a specific time-point. By comparing transcript 
concentrations between conditions you also make assumptions about increased and decreased 
gene transcription in one condition compared to another. mRNA concentrations can however 
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be affected by several factors and mRNA seems to display complicated cycles from synthesis 
in the nucleus until targeted for destruction at the end of its life span (48). mRNA 
concentrations are also a reflection of the balance between transcription and translation. 
Finally, is the half-life of a specific mRNA always the same in different tissues (49)? Or may 
its life span in tissues be shortened by increased translation, i.e. consumed by use? Therefore, 
estimation of gene transcription, pre- mRNA analyses by qPCR or nuclear run on assays, are 
additional possibilities for estimations of transcription and translation analyses of protein 
metabolism.  
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RESULTS 
 
Cell culture experiments 
Amino acids and incorporation of labeled amino acids into protein 
Essential amino acids stimulated incorporation rate of phenylalanine and tyrosine into cellular 
proteins to the same extent, while non-essential amino acids lacked stimulation (Fig. 1A, I). 
Increased incorporation to cellular protein was also seen when medium concentrations of 
either tyrosine (6-405 μM) or phenylalanine (6-405 μM) was increased in combination with 
constant specific radioactivity of L-[14C] tyrosine or L-[14C] phenylalanine respectively. 
However, increased concentration of tyrosine did not stimulate the incorporation rate of 
phenylalanine and vice versa. Also, a lack of stimulation of either tyrosine or phenylalanine 
incorporation rate by essential amino acids was evident when tyrosine or phenylalanine was 
present at high medium concentration (405 μM) in flooding dose experiment (Fig. 1 B, I). 
Similar results were seen when groups of amino acids (aromatics, BCAA, sulphur containing 
AA, Arg, Gln plus others) were used to evaluate potential stimulation of tyrosine and arginine 
incorporation (Fig. 2A,B, I). Thus, stimulation of tyrosine, phenylalanine and arginine 
incorporation rates was demonstrated by groups of amino acids that contained the tracer at 
increasing tracee concentration. Thus, the aromatics stimulated the incorporation of tyrosine 
but not of arginine and vice versa. Similar results were obtained when amino acid 
incorporation was evaluated among different proteins separated by gel electrophoresis.  
 
Autoradiograms of labeled cell proteins after separation in SDS gel gradient electrophoresis 
indicated that a number of proteins were stimulated up to five fold by normal amino acid 
concentrations (Fig. 3, I). However, when the same experiment was performed and both 
radioactivity of [35S]-methionine and the tracee concentration was kept constant, it was 
observed that only some protein fractions indicated truly increased incorporation; i.e. the 
tracer was incorporated more extensively in the presence of high tracee concentrations 
compared to low tracee concentrations in the medium (Fig. 4, I). These results indicate that 
incorporation of amino acids to mixed proteins was not from one homogenous precursor pool, 
or that amino acids initiated various mRNAs differently (Fig. 1A, B).  
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Ribosome profiles 
Amino acids at normal concentrations stimulated protein synthesis indicated by significantly 
more polysomes in such cells. This effect was related to essential amino acids, while non-
essential amino acids did not promote formation of polyribosomes (p<0.01) (Fig.6, I). 
 
Effects of amino acids on initiation of translation 
4E-BP1 was found in complex with eIF4E in cells treated with low amino acid concentrations 
(0.28 mM), while cells exposed to normal amino acid concentration (9 mM) had almost no 
4E-BP1 bound to eIF4E. Cells provided with normal amounts of amino acids (9 mM) had 
almost all 4E-BP1 in the γ form, while cells incubated in the presence of low amino acid 
concentration had no 4E-BP1 present in the highest phosphorylated γ form. Increased amount 
of eIF4G ? eIF4E in complex was seen in cells provided normal amino acid concentrations. 
Fig. 1A. Autoradiogram of [35S]-methionine labeled proteins from starved (St) and refed (Rf) L6 cells 
incubated with low (0.28 mM) or normal (9 mM) concentrations of all amino acids or groups of amino acids. 
1B. Autoradiogram of [35S]-methionine labeled proteins from either starved or refed L6 cells solubilized and 
extracted into four sub-cellular fractions (cytosol, membrane/organelles, nucleus, cytoskeletal, using 
Calbiochems sub-cellular proteome extraction kit). Proteins were separated in a 4-12% Nupage minigel with 
MES buffer system in the presence of SDS. Equal amounts of protein from starved and refed samples were 
applied on the gel. The specific radioactivity of [35S]-methionine and tracee concentration of methionine were 
kept constant among all samples. 
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This confirms that global protein synthesis was more active in the presence of 9 mM amino 
acids in the medium compared to 0.28 mM (Fig. 7, I).  
 
It was confirmed that essential amino acids activated initiation of translation, while non-
essential amino acids had no such effect (Fig. 8, I). Branched chain amino acids (leu, ile, val) 
stimulated initiation of translation while the aromatic (trp, phe, tyr) and sulphatic amino acids 
(met, cys) did not (Fig. 9, I). A group of amino acids with glutamine, histidine, threonine, 
arginine and lysine showed increased initiation of translation. The presence of all three 
branched amino acids in combination were more potent than any of the individual branched 
chain amino acids. Also, glutamine in combination with histidine, arginine, threonine and 
lysine were more potent than glutamine alone (Fig. 10, I).  
 
Effects of insulin on protein synthesis 
The addition of insulin at physiologic concentration (100 μU/ml) had no significant effect on 
amino acid incorporation at either low or normal concentrations of amino acids, while 
pharmacological insulin concentrations (3 mU/ml) stimulated phenylalanine incorporation at 
low amino acid concentration, but significantly more at normal amino acid concentration (9 
mM) (Fig. 11, I). Similar results were obtained by Western blot analyses on initiation factors 
(Fig. 12, I).  
 
Transcription and amino acids 
L6 cells expressed both actin and Myosin heavy chain proteins (Fig. 1, V), but 2A transcripts 
were below detection levels when analyzed by real-time PCR. Acta 1 transcripts were higher 
in starved cells compared to cells refed by amino acids (p<0.05).  
 
Snat 2 (slc38a2) transcripts were decreased in refed cells compared to amino acid starved 
cells (p<0.05) as well as in cells refed by various combinations of amino acids. Cells refed by 
branched chain amino acids (leu, ile, val) or by glutamine in combination with other amino 
acids (arg, thr, his, lys) showed decreased levels of snat 2 transcripts. Refeeding by aromatic 
(phe, tyr, trp) or sulphatic amino acids (met, cys) did not alter snat 2 mRNA levels (Fig. 4, V).  
 
A Gene ontology (GO) search to find categories with significant enrichment of changed 
genes, between amino acid starved and refed cells, was performed on results obtained from 
hybridization of 41 090 probes on the Agilent 4 x 44K whole genome rat array. Nine GO 
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categories with enrichment of entities were found; all related to lipid, cholesterol and steroid 
metabolism (Table 1, V). Additionally, mRNAs for several amino acid transporters and 
contractile proteins demonstrated alterations in transcript levels in response to provision of 
amino acids to cell cultures (Table 3, V). 
 
 
Animal experiments 
Plasma concentrations 
Plasma levels of IGF-I were significantly lower in liver IGF-I knockout mice (Li-IGF-I-/-) 
compared to wild type mice at all nutritional conditions (<0.001), while glucose and insulin 
levels were comparable. Overnight starvation caused a significant decrease in plasma glucose 
compared to freely fed knockouts and wt mice (p<0.05) (Table 1, IV). Branched chain and 
essential amino acids were significantly altered during starvation followed by refeeding in 
wild type mice, but not so in liver IGF-I knockouts. These alterations were also reflected in 
concentrations of all amino acids (Table 2, IV).  
 
Protein metabolism in skeletal muscles  
Basal fractional synthesis rate in liver and muscle tissue was comparable in freely fed wild 
type and liver IGF-I knockout mice. Refeeding increased liver (p<0.10) and muscle protein 
synthesis (p<0.01) compared to starvation in both wild type and liver IGF-I knockout animals 
(Fig. 1A,B, IV). 
 
mRNA transcript levels were comparable in freely fed wild type and knockout mice (IGF-I, 
IGF-IR, PI3-kinase, AKT and mTOR). However, IGF-I transcripts decreased significantly in 
wild type mice during starvation but not so in knockouts. IGF-IR increased during starvation 
in both wild type and knockout mice and remained increased during refeeding (Fig. 2A-B, 
IV). Significant changes in transcript levels of PI3K and AKT were not observed. By contrast, 
mTOR levels were increased in starved knockout animals compared to refed mice without 
any similar change in wild type mice (Fig. 2C, IV). 
 
The 4E-BP1 ? eIF4E complex, 4E-BP1 phosphorylation state, p70s6k phosphorylation and 
mTOR phosphorylation were comparable among wild type and liver IGF-I knockout mice. 
Starvation increased muscle content of 4E-BP1 ? eIF4E complexes with corresponding 
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normalization in refed animals (Fig. 3A, IV). Similarly, the 4E-BP1 phosphorylation state was 
decreased in starved mice compared to freely fed mice with increase in refed wild type and 
liver IGF-I knockout mice. p70s6k and mTOR2448 was less phosphorylated in starved wild 
type and IGF-I liver knockout mice with complete reversal in both groups during refeeding 
(Fig 3C,D,E, IV).  
 
Analyses of eIF4G? eIF4E complex, 4E-BP1? eIF4E complex, 4E-BP1 phosphorylation state 
and p70s6k confirmed that translation initiation of protein synthesis was increased in refed 
mice compared to muscles from starved mice (Fig. 7, I). Starvation-refeeding of normal mice 
(C57 BL/6) reduced and then stimulated initiation of global muscle protein synthesis (p< 
0.01). Mhc2A and acta 1 transcripts were numerically decreased in skeletal muscles from 
refed normal mice compared to starved mice, but the difference did not reach statistical 
significance (Acta 1 p<0.10, MCH p<0.18, n=16) (Fig. 6, V). 
 
 
Clinical investigations 
Plasma concentrations at infusions of different amino acid formulations 
Plasma insulin increased on Vamin 18 and Glavamin infusions compared to basal levels. 
Plasma glucose and serum urea did not change during steady state infusions of different 
amino acid solutions compared to preinfusion levels. Vamin-Glucos caused lower serum urea 
compared to Vamin 18 and Glavamin infusions. Plasma lactate increased during Vamin 18 
infusions compared to both basal state and to the infusions of the other amino acid solutions 
(Table 2, II).  
 
The sum of all amino acids in arterial plasma increased during steady state infusions of the 
three different amino acid solutions versus basal state in ICU patients (Table 3, II), as well as 
of the sum of all essential amino acids. Of non-essential amino acids, only glutamine, taurine, 
and tyrosine did not increase versus basal state (Table 3, II). Alanine, arginine, citrulline, 
glycine, histidine, serine and ornitine showed different concentrations among the amino acid 
solutions. Seen together, Vamin 18 displayed the most clear and highest increase in arterial 
concentrations of amino acids (Table 4, II). 
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Healthy subjects had significantly higher overall concentrations of amino acids in fasted state 
compared to ICU patients on TPN (p<0.01). The sum of all amino acids, as well as the sum of 
all essential and non-essential amino acids increased significantly in venous plasma around 60 
min following oral intake and remained significantly increased for at least 5 hours. ICU 
patients remained with significantly lower (p<0.01) overall concentrations of amino acids 
during steady-state infusions of the amino acid formulations (Fig. 3, II). Unexpectedly, the 
sum of all amino acid in ICU patients on amino acid infusions only reached overall fasting 
levels in healthy volunteers (Fig. 3, II).  
 
Plasma concentrations at infusion of complete TPN formulation 
Plasma glucose and serum insulin, glycerol, triglycerides and S-FFA did not change by 
provision of preoperative TPN compared to saline infusions (Table 3, III). However, total 
plasma amino acids increased during TPN compared to saline infusions. Methionine, 
phenylalanine and threonine increased significantly in the group of essential amino acids, 
while tryptophan and lysine did not change. Only isoleucine increased among the branch 
chain amino acids (Table 2, III). Of non-essential amino acids alanine, arginine, aspartic acid, 
glycine and histidine increased significantly. 
 
Protein metabolism in skeletal muscles during TPN 
Provision of overnight TPN increased formation of active eIF4G·eIF4E complex (p<0.05). 
The inhibitory complex 4E-BP1·eIF4E decreased by TPN (p<0.06) (Fig. 1B, IV). Overnight 
nutrition increased the amount of 4E-BP1 in the most phosphorylated form to 72% compared 
to 60% in patients with only saline infusions (p<0.05)( Fig. 1C, III). TPN over night increased 
the total amount of p70s6k kinase as well as phosphorylation of the protein. p70s6k increased 
by 30% compared to saline treated patients by TPN (p<0.05). Skeletal muscle tissue from 
patients on TPN displayed decreased MHC2A transcript levels compared to muscle tissue 
from patients who received saline only (p<0.05) (Fig. 5, V).  
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DISCUSSION 
 
Around 45 % of the body-weight in adult humans is skeletal muscles, an important nitrogen 
reserve in different stress conditions such as trauma, infection and starvation. A balanced 
regulation of muscle protein synthesis and degradation is needed to maintain muscle mass at 
appropriate functional levels (50). Feeding stimulates synthesis while acute and chronic 
starvation will increase and decrease degradation respectively (51). Mechanisms behind 
controlled protein balance in skeletal muscles over time have been extensively described in 
humans and animals based on studies in a variety of models from subcellular, cellular and 
tissues to organ levels (50). Yet, integrated signals behind protein balance in skeletal muscles 
are not fully understood, although several studies suggest amino acids in combination with 
hormones as insulin, IGF-I and GH as key factors (52), communicated by intracellular 
phosphoproteins (53-55). This thesis project has focused on one side of this balance, the 
synthesis although factors affecting protein degradation are always interconnected to the 
synthesis level by feedback mechanisms. Our focus has also been effects of oral and 
parenteral feeding, since improvements in artificial nutrition could be of great benefit to large 
groups of in- and out-hospital patients.  
 
 
Muscle tissue 
In healthy humans there is a continuous control of protein synthesis and degradation which 
maintains the muscle mass at an appropriate functional status close to constant levels despite 
variations in food availability. In stressed conditions this balance is however disturbed and 
muscle breakdown accelerates the loss of contractile proteins at the expense of functional 
capacity, while protein synthesis may be depressed due to hormonal and substrate alterations 
in order to deviate substrates to more immediate needs as synthesis of acute phase proteins in 
the liver among other purposes (56). 
 
Muscle tissue is a postmitotic tissue unlike most other tissues in the body. The myofibers 
become permanently differentiated soon after birth and will not undergo mitotic division to 
increase myonuclear numbers. All skeletal muscles consist of numerous fibers and each of 
these fibers is made up of successively smaller units. Each such muscle fiber contains several 
hundred to thousands of myofibrils, which has side by side about 1500 myosin filaments and 
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3000 actin filaments that execute muscle contractions. Thus, it is the cross-wise organization 
of actin and myosin that gives skeletal muscle its striated appearance. The myofibrils appear 
inside the muscle fiber in a matrix called sarcoplasm, which is composed of well-recognized 
intracellular components. The myosin filament is made up by 200 or more individual myosin 
molecules, which are composed of two heavy chain molecules twisted around each other and 
4 light chains attached to the myosin heads. The actin molecules are also twisted around each 
other in a helix similarly as the myosin molecule with tropomyosin and troponin attached to 
the actin molecule. (57) (Fig. 2). The size of the contractile unit (actin, myosin, troponin and 
tropomyosin) has to be unchanged or increase in order to maintain or increase the strength of 
muscles. Requirements for additional nuclei to support muscle hypertrophy appear to be met 
by cell proliferation, differentiation and finally fusion of satellite cells, which may be a type 
of muscle stem sells located between the basal lamina and the sarcolemma of muscle fibers 
close to existing myofibers (58).This process seems to be largely dependent on IGF-I 
exposure (59). 
 
 
 
 Fig 2. Structure of skeletal muscle tissue from the level of bundles down to myofibrils, sarcomeres and 
myofilamentory proteins as described in text. 
 
Image from Wikimedia commons. Used with permission (public domain). 
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Several forms of Myosin heavy chain proteins exist and adult human skeletal muscle tissue 
may express three different isoforms of myosin as heavy chain MHC-I, MHC-IIa and MHC-
IIx. In rodents one additional form MHC-IIb is described (46). The myosin gene family is 
located in a cluster on chromosome 17 in humans and on chromosome 11 in mice (60). 
Several studies have confirmed that mRNA abundance for the different isoforms correlate 
with the relative contents of the different MHC protein isoforms expressed in skeletal muscle 
tissue (61, 62).  
 
Muscle strength is mainly determined by the cross sectional area of the muscle bundles and 
fibers and is reflected by the number of sarcomeres working in parallel. The speed of 
movement of a muscle is primarily regulated by the MHC isoforms within various fibers. 
Changes in MHC expression are common after exercise or muscle inactivity, but MHC 
isoform shifts seem to appear in a certain pattern only; Type 1-2A-2X-2B (60, 63). Disuse 
atrophy is related to upregulation of fast MHC isoforms while muscle activity usually up-
regulates the appearance of slower forms of MHC, although it varies with type of muscle 
exercise (64). Fiber type changes in muscles have also been observed in mice suffering from 
cancer cachexia (65).  
 
Recently, naturally occurring antisense RNA of MHC mRNA have been found to be involved 
in the shift of MHC isoforms in skeletal muscles as illustrated by decreased MHC2A mRNA 
and increased MHC2X mRNA at the same time after atrophy induction (66, 67). In our 
studies we found that MHC 2A mRNA as well α-actin mRNA decreased after provision of 
amino acids to cultured muscle cells and in skeletal muscle tissue from patients after 
provision of parenteral nutrition. It is not likely that appearance of antisense transcripts would 
be involved in feeding induced changes of MHC 2A levels or in changes of mRNA levels for 
α-actin protein, which is a single isoform without fiber-type specificity. Also, it has not been 
recognized that nutrition would be associated with fiber type changes. Lately it has been 
reported that introns of myosin genes encode several microRNAs (68-70), suggested to be 
involved in myogenesis and myosin heavy chain production (71, 72). microRNAs are small 
RNA fragments that can repress translation of mRNAs. Interestingly, the expression of 
several microRNAs were altered in skeletal muscles tissues following oral ingestion of 
essential amino acids and thus may be involved in control of muscle protein balance (73). 
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Protein synthesis 
The formation and synthesis of proteins is a complex process initially depending upon the 
transcription of DNA into mRNA followed by translation of spliced mRNA into proteins. 
Translational control of existing mRNAs allows for rapid changes in cellular concentrations 
of proteins compared to transcriptional regulation. The process of protein translation, which is 
the synthesis of proteins, can be divided into 3 distinct phases; initiation, whereby mRNA 
bind to 40S and 60S subunits to form a ribosome complex capable of translation; elongation, 
by which tRNA-bound amino acids are incorporated into the growing polypeptide chains 
according to the mRNA template; and finally termination, where completed proteins are 
released from the ribosomes. Most of the control of protein synthesis is probably exerted at 
the initiation phase (26). This process requires several steps and involves more than a dozen 
of eukaryotic initiation factors (eIFs), although it is not fully understood how this process is 
executed. It is assumed that two steps are particularly important in control of protein synthesis 
rates; the binding of initiator methionyl-tRNA to the 40 S ribosomal subunit, mediated by 
eIF2; and the assembly of the eIF4F-complex. In the latter step, eIF4E binds to the cap 
structure present at the 5´end of eukaryotic mRNAs and then, the eIF4E-mRNA complex 
binds to factor eIF4G and eIF4A to form an eIF4F-complex competent for protein synthesis 
(Fig. 3). The availability of eIF4E to bind mRNA is regulated by a small protein termed 4E-
binding protein 1 (4E-BP1). The 4E-BP1 competes with eIF4G for the same binding site on 
eIF4E and thus prevents assembly of the active eIF4F complex. The 4E-BP1 is regulated by 
the extent of phosphorylation. When 4E-BP1 becomes phosphorylated at specific sites it 
results in release of eIF4E from the inactive 4E-BP · eIF4E complex, which allows eIF4E to 
bind to eIF4G to form active eIF4F complex (27).  
 
In our studies we used the above described steps for estimation of translation and activation of 
protein synthesis. We also measured phosphorylation of other key regulatory proteins 
involved in cell signaling such as mTOR and p70 s6kinase. mTOR is a downstream target in 
the PI3K/akt signaling pathway (among others), and integrates signaling from several stimuli 
related to energy status, hormones and amino acid availability. mTOR is either directly or 
indirectly responsible for phosphorylation of several substrates in the protein synthesis 
machinery including eIF4G, p70s6k and 4E-BP1. p70S6kinase can also phosphorylate several 
proteins including rpS6, eIF4B, S6K1 Aly/REF-like target (SKAR) as well as eukaryotic 
elongation factor 2 kinase. It therefore affects both the initiation and elongation of mRNA  
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Fig 3. Schematic illustration of protein synthesis. The canonical pathway of eukaryotic translation initiation is divided 
into eight stages (2–9). These stages follow the recycling of post-termination complexes (post-TCs; 1) to yield 
separated 40S and 60S ribosomal subunits, and result in the formation of an 80S ribosomal initiation complex, in which 
Met-tRNAMeti is base paired with the initiation codon in the ribosomal P-site and which is competent to start the 
translation elongation stage. These stages are: eukaryotic initiation factor 2 (eIF2)–GTP–Met-tRNAMeti ternary complex 
formation (2); formation of a 43S preinitiation complex comprising a 40S subunit, eIF1, eIF1A, eIF3, eIF2–GTP–Met-
tRNAMeti and probably eIF5 (3); mRNA activation, during which the mRNA cap-proximal region is unwound in an 
ATP-dependent manner by eIF4F with eIF4B (4); attachment of the 43S complex to this mRNA region (5); scanning of 
the 5′ UTR in a 5′ to 3′ direction by 43S complexes (6); recognition of the initiation codon and 48S initiation complex 
formation, which switches the scanning complex to a 'closed' conformation and leads to displacement of eIF1 to allow 
eIF5-mediated hydrolysis of eIF2-bound GTP and Pi release (7); joining of 60S subunits to 48S complexes and 
concomitant displacement of eIF2–GDP and other factors (eIF1, eIF3, eIF4B, eIF4F and eIF5) mediated by eIF5B (8); 
and GTP hydrolysis by eIF5B and release of eIF1A and GDP-bound eIF5B from assembled elongation-competent 80S 
ribosomes (9). Translation is a cyclical process, in which termination follows elongation and leads to recycling (1), 
which generates separated ribosomal subunits. The model omits potential 'closed loop' interactions involving poly(A)-
binding protein (PABP), eukaryotic release factor 3 (eRF3) and eIF4F during recycling, and the recycling of eIF2–GDP 
by eIF2B. Whether eRF3 is still present on ribosomes at the recycling stage is unknown. 
 
Reprinted by permission from Macmillan Publishers Ltd [Nature Reviews Molecular Cell Biology] (26), copyright 
(2010) 
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translation. However, it is still not known how amino acids influence mTOR signaling. 
Perhaps, various cells may use different mechanisms in such control events. Other cell 
signaling pathways, that influence translation is the RAS/MAPK pathway, which is 
responsible for phosphorylation of eIF4E and eIF4B (74, 75). 
 
Branched chain amino acids (BCAA) are the most hydrophobic amino acids and inner parts of 
globular proteins mainly contain leucine, isoleucine and valine. Membrane proteins also need 
hydrophobic amino acids in transmemebrane domains for interactions with hydrocarbon 
chains in lipids. BCAA have other important functions in complex proteins as myosins, 
fibrinogen or keratins that contain coiled-coiled alpha helixes. Thus, many proteins in tissues 
and organs contain high proportions of BCAA and around 35% of our daily need of essential 
amino acids is BCAA, while most dietary proteins contain around 20% BCAA only (76). 
Branched chain amino acids, particularly leucine, are proposed to have special roles in amino 
acid signaling for protein synthesis as well as in other metabolic activities (77, 78). After 
digestion of food, BCAAs are preferentially taken up in skeletal muscles instead of being 
metabolized in the liver as most other amino acids. BCAA are catabolized by two common 
enzymatic steps of which the first is branched-chain aminotransferase (BCAT), which is low 
expressed in liver cells (79). Therefore, BCAAs appear in peripheral tissues in proportions to 
dietary intakes (80). BCAAs are rapidly oxidized in skeletal muscle cells and are more or less 
insulin independent for uptake and oxidation. Leucine may then be a metabolic alternative to 
glucose oxidation in conditions within severe insulin resistance (81).  
 
 
Amino acid transporting 
Translocation of amino acids into the cell from the interstitial fluid occurs via specific amino 
acid transporters (82) whereas the passage of amino acids from the blood stream to the 
interstitial fluid seems to be directed by diffusion, perhaps being a limiting step under some 
circumstances (83, 84). Functionally distinct amino acid transporting systems have been 
defined on the basis of amino acid selectivity. Some of the amino acid transporting systems 
are tissue specific but most of the transporters are ubiquitously expressed in cells (82). System 
A, Asc, N and L are the major amino acid transporting systems. Small, short chained amino 
acids are transported by system A or Asc, while branched chain and aromatic amino acids are 
transported by system L. Intracellular amino acid concentrations in skeletal muscle tissue are 
 33 
higher than observed in extracellular fluids and active transport is used against amino acid 
concentration gradients into the cell (85, 86).  
 
Cells can respond to changes in availability of nutritents by the control of activity in amino 
acid transporting systems. System A transporting can increase after both insulin and IGF-I 
stimulation and such hormone induced responses can be blocked by inhibitors of PI3K 
signaling (87). System A activity is also increased when cells are incubated in an amino acid 
free medium (87, 88). High concentrations of leucine in the medium can regulate system A 
transporting in the presence of other amino acids, but it requires at least 3 hours of incubation 
before system A transporting appears to be increased (89). Starvation induced increase of 
amino acid transporters usually results from increased Vmax with no change in Km of the 
transporters, where Vmax reflects the transporting capacity and Km the affinity to the 
transporter. Upregulation of transporting seems to be dependent on translocation of a pre-
made pool of transporters to plasma membranes as well as depending on de novo synthesis 
(88). In the present studies we evaluated how provision of extracellular amino acids 
influenced mRNA content of the transporter Snat2. We found that the transcription of Snat2 
(encoded by the gene slc38a2), was affected by refeeding muscle cells with amino acids in 
various combinations. Several amino acids such as glutamine, histidine, cystein and 
methionine are transported by Snat2, while branched chain- and the aromatic amino acids are 
transported by system L across cell membranes (82, 90). We found that Snat2 mRNA was 
increased in starved cells compared to cells refed by amino acids, consistent with increased 
system A transporting after amino acid withdrawal. Concentrations of Snat2 mRNA were 
decreased when cells were refed by groups of amino acids, as gln, his, lys, arg and thr only. 
Refeeding cells by branched chain amino acids also decreased Snat2 mRNA, although these 
amino acids are transported by system L, which is operating as an 1:1 amino acid exchanger 
that may couple influx of branched chain amino acids to efflux of cytoplasmatic amino acids 
such as glutamine (87). It is then possible that refeeding with branched chain amino acids 
caused efflux of other amino acids to the extent that extracellular concentrations of neutral 
amino acids increased enough to alter Snat2 mRNA levels. If so, Snat2 should be controlled 
by extracellular availability of either glutamine or histidine, since it was not changed by 
refeeding with cysteine or methionine, which are specific Snat2 substrates. Our present and 
others results, that Snat2 mRNA and transporting are up-regulated by amino acid deprivation, 
are however in contrast with a new report examining amino acid transporter expression in 
human skeletal muscle tissue after drinking a mix of essential amino acids. It was reported 
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that mRNA for amino acid transporters SNAT2/SLC38A2 and PAT1/SLC36A1 were 
transiently up-regulated one hour after ingestion of essential amino acids. SNAT2 mRNA 
expression was also followed by increased protein expression of SNAT2, 2-3 hours post 
ingestion of amino acids (91).  
 
It has not yet been finally assessed how amino acids signal across cell membranes to elicit 
intracellular triggers for induction of translation initiation of proteins, although it has been 
discussed for decades whether there may be extracellular amino acid sensors or whether cells 
are sensitive to alterations of intracellular amino acid concentrations monitored in control of 
net protein balance. Phyllogenetically, it makes sense that extracellular amino acid 
concentrations should be communicated to the intracellular compartment when available for 
induction of protein synthesis. A simplistic model could be that amino acid transporters are 
sensitive to increasing levels of extracellular amino acids. If so, net influx will occur (6). This 
model is also proposed by Bohe who suggested that protein synthesis is regulated by 
extracellular and not intracellular amino acids based on the findings that intracellular levels of 
amino acids initially decreased when protein synthesis was stimulated (92). On the other 
hand, it has been suggested from cell culture experiments that intracellular amino acids, 
especially leucine levels, may be a trigger in cell signaling to protein synthesis (93). Recent 
research has however proposed amino acid transporters to function as hybrid transporter-
receptors (tranceptors) whereby structural changes during amino acid transport cycles could 
be transduced to intracellular signaling pathways perhaps via PI3K kinase or JNK mediated 
signaling (85).  
 
 
Clinical investigations 
Even in the early era of clinical nutrition, it was observed that artificial nutrition was rather 
inefficient to promote re-synthesis of lost whole-body proteins, such as circulating albumin, 
intestinal mucosa, various immune proteins and skeletal muscles as well. Our own 
observations have particularly focused on the skeletal muscle compartments of chronically ill 
patients where cancer wastage represents a major group (2, 4, 94). Earlier, it was observed 
that both enteral and parenteral nutrition were inefficient to support net influx of amino acids 
across skeletal muscle beds (4, 95). These results were later on confirmed by findings that 
standard clinical nutrition effectively attenuated net break down of muscle proteins, although 
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it was considerably more difficult to initiate re-synthesis of overall whole-body proteins to net 
gains (5). In the light of such results amino acids may be a limiting component of intravenous 
feeding. If so, it is interesting to consider effects of different amino acid compositions in 
commercially available formulations. The scientific basis for such speculations is findings 
that amino acids in themselves stimulate muscle protein synthesis in skeletal muscles 
evaluated in human models (11, 96, 97). A potential role of amino acids was confirmed 
showing that primed constant infusions of amino acids at increasing dose rates were translated 
into increased net uptake of all amino acids across peripheral skeletal muscles beds in healthy 
volunteers. Such findings suggested that circulating arterial concentrations of amino acids 
were related to amino acid profiles in the infusion formulations as well as to dose rates of 
individual amino acids as significant factors. These observations may explain observed 
therapeutical inefficiency of clinical nutrition due to limitations in the amino acid availability 
(98). Based on this background it is important to consider how amino acid formulations 
should be designed to represent more optimal treatment (99). However, restricting 
prerequisites for industrial development of improved amino acid formulations are based on 
technical possibilities to create optimal amino acid formulations. Therefore, we decided to 
evaluate whether different commercially available amino acid solutions are actually translated 
into different amino acid profiles in arterial blood during infusion at steady-state conditions in 
critically ill patients. If not so, there should be little justification for modifications of amino 
acid profiles in parenteral feeding formulations.  
 
Our results demonstrate that ICU patients had significantly lower over all amino acid blood 
concentrations in basal state conditions compared to fasted healthy volunteers (100). This 
may reflect that amino acid oxidation was significantly increased, since overall protein 
balance is usually negative in ICU patients (101). Thus, it obviously requires a considerable 
amount of amino acids to support both substrate oxidation and elevation of arterial 
concentrations to be high enough to switch net outflow of amino acids to net cellular inflow 
for protein synthesis, particularly in the large skeletal muscle pool. Amino acids were then 
provided at rates corresponding to 0.2 gN/kg/day. This rate has earlier been confirmed to 
switch net outflux to influx of amino acids across peripheral tissues in our healthy volunteers 
(6, 12). However, this dose rate of infusions to ICU patients did not increase overall blood 
amino acid concentrations higher than fasting plasma levels in healthy volunteers (Fig. 2, II). 
Therefore, it is not likely that such amino acid regimens should be enough to initiate 
translation of protein synthesis in skeletal muscles by amino acids only.  
 36 
In our next study we evaluated initiation factor complexes after infusion of a constant and low 
dose of amino acids (~43 mg/kg/h) to patients scheduled for upper gastrointestinal surgery 
(18). Despite the fact that those patients had comparable plasma amino acid levels as our 
patients in study II they responded to the nutrition with alterations in initiation factor 
complexes and increased p70s6kinase phosphorylation. However, as discussed in the methods 
section, it may be questioned to what extent protein complex formation and protein 
phosphorylation changes really reflect protein synthesis activity. On one hand, numerous data 
from rats, mouse and pigs are available, which show that changes of initiation factors with 
increasing eIF4G⋅eIF4E and decreasing 4E-BP1⋅eIF4E complexes should be related to 
elevated protein synthesis. However, exceptions to these reports occur where increased and 
decreased protein synthesis was not reflected by changes of initiation factors in muscle tissue 
(102-104). Similar studies on human skeletal muscles are limited, but infusion of BCAA 
increased the amount of 4E-BP1 in the gamma form and increased phosphorylation of p70s6k 
without increased protein synthesis in skeletal muscles (105). However, infusion of mixed 
amino acids caused similar changes in 4E-BP1 phosphorylation simultaneously with 
increased protein synthesis (106). Therefore, it seems important to measure eIF4G complexes 
as performed in the present study.  
 
In Study III we used a constant low dose amino acid infusion (~ 43 mg/kg/hr), which 
compares well with a low dose used by Bohé et al (43.5 mg/kg/hr) inducing a 30% increased 
mixed muscle protein synthesis (92). However, another study by Bohé et al indicated that 
muscle protein synthesis may became refractory despite continuous availability of amino 
acids (107). By contrast, our present results showed sustained activation of proteins for 
initiation of translation during 16 hours infusion of a low dose of amino acids (18). This 
difference may be explained by amino acid overloading secondary to a high dose infusion 
indicated by appearing ureagenesis as reported (107). Also, it is likely that activated 
phosphoproteins reflect continuously changing recruitment of various mRNAs for translation 
indicated by sustained formation of initiation complexes. Therefore, selection of investigative 
methods should always be considered with the specific aim in mind, where quantification of 
initiation complexes seems ideal for determination of directional changes of protein synthesis 
in non-steady state conditions particularly.  
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Insulin-like growth factor 1 (IGF-I) 
Anabolic effects by IGF-I are well recognized, particularly such as stimulation of protein 
synthesis related to cell proliferation, tissue growth and cell differentiation (108, 109). The 
IGF system is comprised of two ligands, IGF-I and IGF-2, six binding proteins (IGFBPs 1-6) 
and the IGF-IR, which mediates most of the cellular signaling functions in this system (110). 
IGFs are transported in the circulation bound to the IGFBPs, which regulate its ability to bind 
to receptors. Following receptor binding, the receptor undergoes a conformational change 
leading to activation of its intrinsic tyrosine kinase, which autophosporylates additional 
tyrosines that act as docking site for IRS-1, a site for several signaling intermediates including 
p85; the regulatory subunit of PI-3-kinase (PI3K). PI3K activation leads to phospholipid 
generation in the plasma membrane, which recruits and activates AKT leading to activation of 
mTOR and p70s6kinase (p70s6K), which may induce increased protein synthesis. IGF-I 
ligand binding can also activate Shc/RAS/MAP kinase pathway leading to mitogenesis. 
 
Original knockout studies of the IGFs showed that the development of most tissues and 
organs is controlled to some extent by the IGF system (111, 112). These studies showed that 
mice lacking either IGF-I or IGF-2 genes are born severely growth retarded, with bodyweight 
approximately ~60 % of wild-type mice. Mice lacking a functional IGF-IR were even smaller 
and died soon after birth (111). In the mid 1990s the Cre-lox P technique was introduced for 
inducible knockout of genes (113, 114) and made it possible to produce inducible tissue 
specific knockouts. In use of such mice it was found that the liver is the main producer of 
IGF-I in the circulation and that mice with post-natal hepatic deletion of the IGF-I gene grew 
almost normally, suggesting that local tissue IGF-I is the main determinant of post-natal body 
growth (19). Local IGF-I expression also seems to have a well-defined role in exercise related 
muscle growth and satellite cell proliferation (59, 108). Increased IGF-IR mRNA and IGF-I 
protein levels have been reported in response to exercise (115-117), although load-induced 
hypertrophy can occur in mice with non-functional IGF-IR (118), indicating that increased 
protein synthesis is not entirely dependent on signaling through the IGF-IR. 
 
It has also been assumed that circulating IGF-I may be involved in promotion of diurnal 
alterations of muscle protein synthesis in response to meal feeding (119). Malnourished 
patients have usually decreased plasma IGF-I levels and both plasma IGF-I and muscle IGF-I 
mRNA can be influenced by diet (120). However, a complex situation, with protein bound 
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circulating and locally produced IGF-I makes it difficult to demonstrate defined roles for all 
these various factors, particularly when binding proteins themselves may have independent 
regulatory functions across muscle membranes (121, 122). Accordingly, earlier attempts to 
study nutritional effects by IGF-I have not provided unanimous and conclusive results (8, 11, 
123). Injection of anti IGF-I antibodies before feeding attenuated a subsequent rise in protein 
synthesis by 25%, while ip. injections of IGF-I to overnight starved mice only increased 
protein synthesis marginally (11). Studies on genetically altered mice implied that fractional 
resynthesis of muscle protein was unrelated to circulating GH, blood IGF-I and locally tissue 
produced IGF-I mRNA (123). On the other hand, it has been reported that a one hour iv. 
infusion of IGF-I to overnight starved mice increased muscle protein synthesis to levels 
comparable to fed mice (124). Furthermore, reducing free plasma IGF-I to 50% of normal 
levels, by infusion of IGF binding protein 1, decreased muscle protein synthesis by 25% with 
decreased phosphorylation of p70s6k (125), and provision of IGF-I/IGFBP-3 complex 
improved sepsis induced muscle catabolism (126). Also, plasma IGF-I did not diverge from 
basal levels in humans who received a drink of essential amino acids at a time when muscle 
protein synthesis was stimulated by more than 100 % (127). By contrast, when IGF-I were 
infused directly into arm muscle beds, compared to systemically raised IGF-I, protein 
synthesis was only increased subsequently to locally infused IGF-I (128).  
 
In our present experiments, we used liver IGF-I deficient mice to study activation of protein 
synthesis following feeding. We found no difference between liver IGF-I deficient and wild 
type mice regarding protein synthesis rate or translational control of protein synthesis in 
skeletal muscles. Both mouse groups showed increased protein synthesis rate after refeeding 
compared to overnight starvation and similar alterations in phosphorylation status of 4E-BP1, 
p70s6kinse, mTORser2448 and association of the 4E-BP1·eIF4E complex. Thus, effects by 
circulating IGF-I seemed less important for the control of translation initiation of protein 
synthesis compared to other possible factors such as plasma or extracellular amino acids. Both 
liver IGF-I knockouts and wild type mice showed increased mRNA expression of the IGF-IR 
during starvation. This increased receptor expression may thus reflect a positive feed back 
control of IGF-I signaling secondary to extra- or intracellular IGF-I close to membranes; a 
conclusion supported by observations in cultured cells with increased IGF-IR number and 
promoted amino acid transport in relationship to decreased extracellular concentration of 
amino acids, particularly of glutamine (6, 129). Consistent alterations of IGF-IR mRNA were 
observed in our experiments while IGF-I mRNA in skeletal muscle tissue seemed more 
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variable among starved and refed mice. Thus, IGF-IR expression may be more tightly 
controlled than tissue IGF-I expression in skeletal muscle metabolism in response to 
starvation – refeeding. There were no changes in either PI3K or AKT mRNA expression, 
while mTOR expression was up-regulated in starved IGF-I knockouts without apparent 
changes in protein phosphorylation. This up-regulation in starved knockouts may therefore 
reflect compensatory effects unrelated to phosphorylation of mTOR secondary to decreased 
circulating IGF-I. This condition would also explain why IGF-I expression did not decrease to 
the same extent in starved IGF-I knockouts as observed in wild type mice. Therefore, effects 
by circulating IGF-I seems less important for alterations of protein synthesis in response to 
feeding compared to other factors, for example increased flux of extracellular amino acids 
across cell membranes. 
 
 
Insulin 
For years it has been debated whether insulin is an important stimulator of overall protein 
synthesis in skeletal muscles, although it has been repeatedly shown in cell culture and animal 
experiments that supraphysiological levels of insulin stimulate protein synthesis 
independently of the presence of amino acids (130-132). Some human experiments have 
however made doubts on the role insulin may have in physiological settings to activate 
muscle protein synthesis (133-135). Also, we have earlier reported that knockout mice with 
overt diabetes displayed close to normal fractional synthesis rate of overall muscle proteins 
during re-feeding; observations that may also question an absolute or permissive role for 
insulin to support skeletal muscle protein synthesis (11). However, it is usually believed that 
insulin has a permissive role to support protein synthesis at feeding and other conditions as 
supported by a recent report on adult individuals, where reduced amino acid concentrations 
during increased nutrient and insulin availability blunted mTOR/S6K1 signaling in 
relationship to muscle protein synthesis (136-138). Therefore, at least amino acids are 
necessary for a physiological activation of mTOR/S6K1 and subsequent protein synthesis in 
human skeletal muscle (138).  
 
The effect on protein synthesis by insulin was evaluated by different methods in our present 
studies. Incorporation experiments revealed that insulin at physiological levels did not clear 
cut stimulate overall phenylalanine incorporation into muscle proteins while pharmacological 
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concentrations (3 mU/ml) increased incorporation significantly, more so at normal than at low 
medium concentrations of amino acids, which was also confirmed by our Western blot 
analyses on initiation factors (17). These results indicate that pathways for initiation of 
translation of muscle proteins by insulin and amino acids may either in part be different (106, 
139) or suggesting that insulin and amino acids may stimulate different proteins. Insulin may 
also control transcription either positively or negatively.  
 
 
Mevalonate pathway and steroid hormones 
Computer searches on Gene ontology (GO) categories revealed that amino acids had 
pronounced effects on steroid biosynthesis and lipid metabolism in skeletal muscle cells. Our 
present microarray experiments also indicated that a large number of transcripts (30%) across 
large parts of the genome were changed following amino acid provision. Cholesterol and 
steroid hormones are produced by enzymes in the mevalonate pathway (140) and it was 
interesting to find that most enzymes in this pathway were increased in skeletal muscle cells 
following amino acid provision to cell cultures. It was recently reported that skeletal muscle 
cells are capable of local synthesis of sex steroid hormones, where testosterone can be 
synthesized from dihydroepiandosterone (DHEA) in the circulation (141). Thus, testosterone 
may be synthesized from either cholesterol in cell membranes or through metabolism of 
DHEA by 17β-hydroxy-steroid dehydrogenases (140), which increased in L6 cells refed by 
amino acids. The expression of these hormones can also increase after exercise and may 
therefore represent an important part of anabolic responses to physical training in skeletal 
muscles (142). The first step in the mevalonate pathway is also a target in treatment with 
cholesterol lowering drugs as statins. Accordingly, lovastatin treatment of cells has been 
reported to inhibit protein synthesis rate and to induce phosphorylation changes of translation 
regulatory proteins (p70s6k, 4E-BP1 and eIF4E) (143). Well-known transcription factors for 
cholesterol and fatty acid metabolism, sterol regulatory element binding protein (SREBP) 1A 
and 1C, are also induced by activation of the PI3K/ AKT pathway or MAPkinase pathways by 
insulin and growth factors (144-147) This suggests additional functions in skeletal muscle 
cells at low rate of lipid synthesis (148, 149). Thus, amino acids may control skeletal muscle 
protein balance by several mechanisms related to both acute and more long-term alterations at 
feeding. 
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Concluding remarks 
Our present studies represent different aspects with possible importance to the complex cell 
machinery for protein synthesis in skeletal muscles. Should there be any impact and 
possibility to improve nutritional treatment of patients in the need of nutritional support it 
must be possible to provide amino acids to skeletal muscles via the blood circulation in order 
to increase extracellular amino acid concentrations by the infused solutions as evaluated in 
our ICU and preoperative patients. However, not all provided amino acids appeared with 
increased concentrations in blood and some amino acids remained unchanged, although 
delivered at increased amounts. This shortcoming may hamper the effectiveness of 
intravenous nutrition. However, we confirmed that TPN infusions activated translation 
initiation of muscle proteins, which was indicated by changes of initiation factor complexes as 
well as increased p70s6 kinase phosphorylation as markers to reflect increased protein 
synthesis in muscle tissue. We also found that the amino acid transporter Snat2 mRNA was 
regulated by feeding cells with different combinations of amino acids. Changes in 
concentration of extracellular amino acids may thus be sensed by amino acid transporters, 
which may signal to muscle cells that extracellular amino acids are available for protein 
synthesis and intermediary metabolism. 
 
IGF-I mRNA was measured as a representative for the influence of growth factors on protein 
synthesis in muscles. We found that IGF-I mRNA and IGF-IR mRNA were controlled by 
starvation-refeeding in muscle cells, but circulating IGF-I seemed to have a minor role in 
feeding induced upregulation of muscle protein synthesis. It was also possible to influence on 
cellular transcript levels of IGF-I by refeeding cultured L6 cells with amino acids 
(unpublished results) suggesting a possible link between extracellular amino acid 
concentrations and local IGF-I production within cells, although mechanisms are unclear. A 
most well-recognized signaling pathway for IGF-I effects is PI3K/AKT/mTOR. System A 
transporting is also connected to PI3kinase, supported by findings that pre-incubation of cells 
with a PI3kinase inhibitor prevented amino acid starvation induced changes in system A 
transporting (88). Likewise, leucine induced increase in system A transporting was possible to 
block by either PI3kinase or mTOR inhibitors (89). Also, in microarray experiments we found 
indications that mevalonate pathway metabolism was connected to the metabolism of amino 
acids in muscle cells. These observations support our speculations that anabolic reactions in 
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muscle tissue, secondary to amino acid metabolism, may be related to local muscle steroid 
production which makes sense. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4. Possible interactions among amino acids, IGF-I and local muscle production of steroid hormones 
across well-recognized pathways for signalling to induce translation of initiation of muscle protein 
synthesis. Increased extracellular levels of amino acids interact with various amino acid transporters (Snat 2) 
for communication of altered flux of amino acids aimed to build proteins.  
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